Loading clinical trials...
Loading clinical trials...
A Three-Part Phase 1 Study to Evaluate the Potential Drug-Drug Interactions Between Vemircopan and Rosuvastatin, Metformin, Levonorgestrel-Ethinyl Estradiol-Containing Oral Contraceptives, and Carbamazepine in Healthy Adult Participants
Conditions
Interventions
Vemircopan
Rosuvastatin
+3 more
Locations
1
United States
Research Site
Brooklyn, Maryland, United States
Start Date
January 17, 2024
Primary Completion Date
April 12, 2024
Completion Date
April 12, 2024
Last Updated
August 12, 2025
NCT07310901
NCT06342713
NCT07401472
NCT07412353
NCT07280858
NCT07300189
Lead Sponsor
Alexion Pharmaceuticals, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions